Marina Amorim Lopes

Marina Amorim Lopes

Auto-generated profile, based on publicly available information

Marina Amorim Lopes

Universidade Estadual Paulista, Brasil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Ciencia & Saude Coletiva
Verified
Journal Article
Open access
KPKarina Pavão Patrício
Karina Pavão Patrício
AMArthur Cesar dos Santos Minato
Arthur Cesar dos Santos Minato
ABAna Flavia Brolio
Ana Flavia Brolio
MLMarina Amorim Lopes
Marina Amorim Lopes
GBGabriela Ribeiro de Barros
Gabriela Ribeiro de Barros
GBGuilherme Correa Barbosa
Guilherme Correa Barbosa
Resumo O uso de plantas medicinais (PM) favorece a integralidade do cuidado na atenção primária à saúde (APS), valorizando o saber popular e o autocuidado. Esta revisão integrativa de literatura objetiva analisar estudos sobre a inserção do uso de PM na APS. A estratégia PICO norteou a busca de evidências, reunindo 18 artigos publicados de janeiro de 2015 a agosto de 2020 nos bancos de dados Biblioteca Virtual de Saúde e PubMed. As variáveis de análise foram o conhecimento dos profissionais da saúde da APS sobre PM e políticas associadas, o uso de PM pelos usuários, destacando seu perfil, fatores que favorecem o uso e a falta de segurança no uso de PM. A literatura aponta insuficiência de conhecimento dos profissionais de saúde sobre as políticas de práticas integrativas e complementares e o uso de plantas para fins medicinais. Os principais usuários são mulheres, idosas, com baixa renda e escolaridade, tanto no Brasil quanto em outros países. Sobre a segurança no uso de PM, frequentemente não há correta identificação de espécie, origem, preparo e dose adequada para cada caso. Por fim, a não abordagem desses conteúdos durante a formação de profissionais da saúde gera menos conhecimento, menos pesquisas e mais preconceito por falta de informação, prejudicando o incentivo e divulgação à comunidade.

1 January 2025 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
DSD.N. Shintaku
D.N. Shintaku
MLM.A. Lopes
M.A. Lopes
RBR.F. Beraldo
R.F. Beraldo
EOEllen Cristina Souza Oliveira
Ellen Cristina Souza Oliveira
GHG.S.P. Herrerias
G.S.P. Herrerias
LSLigia Yukie Sassaki
Ligia Yukie Sassaki
Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is characterized by chronic inflammation, which may be associated with hepatic and biliary manifestations such as non-alcoholic fatty liver disease (NAFLD). Despite the high risk of hepatic manifestations among patients with IBD, few studies in Brazil have assessed the frequency of these diseases. Therefore, this study aimed to analyze the prevalence of liver disease by ultrasound in patients with IBD. This was a single-center, cross-sectional study that included patients with IBD who were followed up at an outpatient clinic. The clinical and sociodemographic data, disease activity, biochemical test results, and Doppler liver ultrasonography results were assessed. Descriptive and association tests were used for statistical analyses. A total of 138 patients were included: 64.49% females, mean age 45.55±14.17 years, and body mass index of 26.92±5.07 kg/m2. In total, 63 (45.65%) patients had CD and 75 (54.35%) had UC. Most patients were in either clinical (58.39%) or endoscopic remission (52.55%). Liver ultrasound revealed NAFLD in 58 patients (42.03%), which was classified as mild (36.21%), moderate (46.55%), or severe (17.24%). Seven patients had choledocholithiasis and three had chronic liver disease. Liver disease was associated with changes in aspartate aminotransferase (AST), alanine aminotransferase (ALT), hematocrit, hemoglobin, and fasting glucose levels. Liver disease is frequent in IBD patients, with NAFLD being the most prevalent. Screening for liver disease in patients with IBD is recommended for early detection and immediate treatment of the alterations, in order to prevent complications and progression to cirrhosis.